STONERIDGE INVESTMENT PARTNERS LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
STONERIDGE INVESTMENT PARTNERS LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$215,000
-73.1%
8,041
-85.7%
0.14%
+6.0%
Q1 2018$798,000
+35.3%
56,176
-22.0%
0.13%
+42.6%
Q4 2017$590,000
-30.8%
71,9980.0%0.09%
-29.9%
Q3 2017$853,000
-19.1%
71,998
-31.4%
0.13%
-14.6%
Q2 2017$1,055,000
-65.7%
104,932
-60.2%
0.16%
-62.1%
Q1 2017$3,072,000
+128.4%
263,730
-8.9%
0.41%
+126.2%
Q4 2016$1,345,000
-40.0%
289,3440.0%0.18%
-43.7%
Q3 2016$2,240,000
+25.1%
289,344
-2.1%
0.32%
+21.7%
Q2 2016$1,791,000
-28.9%
295,4820.0%0.27%
-27.6%
Q1 2016$2,518,000
-36.5%
295,482
-11.2%
0.37%
-30.9%
Q4 2015$3,968,000
+54.2%
332,576
+30.2%
0.53%
+47.9%
Q3 2015$2,574,000
-39.7%
255,397
-0.8%
0.36%
-31.5%
Q2 2015$4,269,000
-10.7%
257,335
-16.7%
0.53%
-6.1%
Q1 2015$4,779,000
+30.9%
308,744
+33.9%
0.56%
+16.6%
Q4 2014$3,652,000
+409.3%
230,525
+243.1%
0.48%
+353.8%
Q3 2014$717,000
+13.4%
67,198
-0.1%
0.11%
+11.6%
Q2 2014$632,000
+32.2%
67,255
-3.0%
0.10%
+3.3%
Q1 2014$478,000
+72.6%
69,305
-2.5%
0.09%
+73.6%
Q4 2013$277,000
+71.0%
71,105
+121.2%
0.05%
+51.4%
Q3 2013$162,00032,1420.04%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders